SNSE/AMGNCL (SNSE/AMGNCL)

Santiago Stock Exchange: SNSE/AMGNCL · CLP

CLP 442,090

+24859.98 (+6.0%)· Recorded snapshot

Market cap	237.8T
Revenue (ttm)	35.1T
Net income (ttm)	8.1T
EPS (ttm)	CLP 15,870
P/E (trailing)	27.9x
P/E (forward)	18.9x
Dividend	CLP 8,941 (2.02%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 35.1T
Net income (ttm): 8.1T
EPS (ttm): CLP 15,870
P/E (trailing): 27.9x
P/E (forward): 18.9x
Market cap: 237.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.9

P25 n/aP50 n/aP75 n/a

Trailing P/E27.9

P25 n/aP50 n/aP75 n/a

ROE91.5

P25 n/aP50 n/aP75 n/a

ROIC19.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/AMGNCL indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-11-03
Employees	31,500
Employees change	3,500
Employees growth	12.5%
Enterprise value	CLP 280.4T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-25
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US0311621009
Last refreshed	2026-10-28
Market cap	CLP 237.8T
Next earnings date	2026-11-03
Price	CLP 442,090.00
Price currency	CLP
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	snse/AMGNCL
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	3.59%
EV/Earnings	34.81x
EV/EBIT	22.44x
EV/EBITDA	16.29x
EV/FCF	29.91x
EV/Sales	7.49x
FCF / EV yield	3.34%
FCF yield	3.94%
Forward P/E	18.88x
Graham number	77496.34047
Graham upside	-81.43%
Lynch fair value	CLP 123,744.88
Lynch upside	-70.34%
P/(FCF - SBC) ratio	26.66x
P/(OCF - SBC) ratio	21.54x
P/B ratio	22.09x
P/E ratio	27.86x
P/FCF ratio	25.37x
P/OCF ratio	20.69x
P/S ratio	6.78x
Price/EBITDA ratio	14.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	24.96%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	CLP 255.7M
Profitable quarters	9
Profitable years	23
Revenue per employee	CLP 1.1B
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -2.1T
Depreciation and amortization	CLP 4.5T
EBIT	CLP 11.7T
EBITDA	CLP 15.9T
EPS	CLP 15,870.00
Financing cash flow	CLP -3.8T
Free cash flow	CLP 9.4T
Free cash flow minus SBC	CLP 8.9T
Gross profit	CLP 25.2T
Income taxes	CLP 1.4T
Investing cash flow	CLP -2.2T
Net borrowing	CLP 1.3T
Net cash flow	CLP 5.5T
Net income	CLP 8.1T
Operating cash flow minus SBC	CLP 11T
Operating income	CLP 11.7T
Revenue	CLP 35.1T
Stock-based compensation	CLP 453.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.89
Book value per share	CLP 19,918.89
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	CLP 18.4T
Interest coverage	4.14
Long-term assets	CLP 53.6T
Long-term liabilities	CLP 52.2T
Net cash (debt)	CLP -39.9T
Net cash / market cap	-16.78%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	CLP 8.4T
Shareholders' equity	CLP 10.8T
Tangible book value	CLP -25.3T
Tangible book value per share	CLP -46,809.74
Total assets	CLP 88.1T
Total cash	CLP 12.9T
Total debt	CLP 52.8T
Total liabilities	CLP 77.3T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	CLP 34.5T
Current liabilities	CLP 25.1T
Current ratio	1.37
Inventory turnover	1.67
Net working capital	CLP 843B
Quick ratio	0.95
Working capital	CLP 8.7T
Working capital turnover	4,466.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	-0.67%
Dividend growth (3Y)	8.6%
Dividend growth years	4
Dividend payment date	2026-09-11
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	CLP 8,940.90
Dividend yield	2.02%
Ex-dividend date	2026-08-21
Last dividend	CLP 2,324.57
Payout ratio	60.45%
Shareholder yield	1.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CLP 334,075.60
1D price change	5.96%
1M price change	11.47%
1M total return	11.47%
1W price change	3.04%
1W total return	3.04%
1Y price change	42.19%
1Y return CAGR	46.37%
1Y total return	46.33%
20-day SMA	CLP 403,821.50
200-day SMA	CLP 323,916.70
3M price change	22.8%
3M total return	23.55%
50-day SMA	CLP 392,420.20
50-day SMA vs 200-day SMA	50over200
52-week high	CLP 442,090.00
52-week high date	2026-10-26
52-week low	CLP 274,700.00
52-week low date	2025-10-29
6M price change	42.19%
6M total return	44.16%
All-time high	CLP 417,230.00
All-time high date	2026-10-20
All-time low	CLP 256,560.00
All-time low date	2024-04-11
Average true range (ATR)	CLP 2,694.77
Average volume	0
Change from 52-week high	0%
Change from 52-week low	60.94%
Change from all-time high	0%
Change from all-time low	62.62%
Monthly RSI	94.81
Previous close	CLP 417,230.00
Price vs 150-day SMA	24.89%
Price vs 20-day SMA	3.32%
Price vs 200-day SMA	28.81%
Price vs 50-day SMA	6.32%
Relative volume	5
RSI	75.18
Sharpe ratio	1.56
Sortino ratio	3.68
Weekly RSI	72.49
YTD price change	42.19%
YTD total return	45.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.82%
Short ratio	4.8 days

Deeper analysis on SNSE/AMGNCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/AMGNCL report

Is a complete SNSE/AMGNCL research report available?

No complete published report is available for snse/AMGNCL (SNSE/AMGNCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/AMGNCL (SNSE/AMGNCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/AMGNCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/AMGNCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/AMGNCL

Frequently asked questions